Dr. Lal Pathlabs Ltd.
NSE: LALPATHLAB · Healthcare
Sector
Healthcare
Size band
Small cap
Market cap
22,885cr
P/E
44.4
ROE
26%
Dividend yield
0.9%
No price is shown on this page, live or delayed. It records what management said on the earnings call, and the company’s filings.
Measured against
Peer set
Hospital & Healthcare Services · largest 12 of 23 measured at Q1 FY27 · financials via Screener| Company | Operating margin | Revenue growth |
|---|---|---|
| Apollo Hospitals Enterprise Ltd. | 16.0% | 20.6% |
| Max Healthcare Institute Ltd. | 25.0% | 16.7% |
| Fortis Healthcare Ltd. | 21.0% | 17.4% |
| Narayana Hrudayalaya Ltd. | 17.0% | 78.1% |
| Aster DM Healthcare Ltd. | 20.0% | 21.6% |
| Global Health Ltd. | 22.0% | 26.5% |
| Krishna Institute of Medical Sciences Ltd | 19.0% | 35.3% |
| Dr. Lal Pathlabs Ltd. | 31.0% | 19.1% |
| Rainbow Children's Medicare Ltd. | 29.0% | 33.1% |
| Sanofi Consumer Healthcare India Ltd. | 38.0% | 6.8% |
| Metropolis Healthcare Ltd. | 25.0% | 16.6% |
| Vijaya Diagnostic Centre Ltd. | 43.0% | 22.9% |
No guidance on record.
This section quotes what management told the market on the quarterly earnings call. We have not transcribed one for Dr. Lal Pathlabs Ltd..
On air
3 calls · outcomes not trackedRecorded as stated on air, with the analyst's SEBI registration status where it was given. Anchor calls carry no registration and are marked. Bharatstox does not make, endorse or repeat these calls, and none of them is our view.
| Channel & show | Aired | Stated target | Stated stop | Outcome |
|---|---|---|---|---|
| CNBC AwaazCNBC Awaax · no registration attached | 27 Aug | +8.9% | -2.0% | still open |
| CNBC AwaazCNBC Awaax · no registration attached | 27 Aug | +8.5% | -2.3% | still open |
| CNBC AwaazCNBC Awaax · no registration attached | 26 Aug | +8.2% | -2.6% | still open |
Filings
latest 25 of 252- General Updates27 Aug 2026
- Attached27 Aug 2026
- General Updates19 Aug 2026
- ESOP/ESOS/ESPS6 Aug 2026
- Analysts/Institutional Investor Meet/Con. Call Updates30 Jul 2026
- Analysts/Institutional Investor Meet/Con. Call Updates24 Jul 2026
- Investor Presentation24 Jul 2026
- Press Release24 Jul 2026
- ESOP/ESOS/ESPS24 Jul 2026
- General Updates24 Jul 2026
- Record Date24 Jul 2026
- Outcome of Board Meeting24 Jul 2026
- Dividend24 Jul 2026
- Outcome of Board Meeting24 Jul 2026
- General Updates17 Jul 2026
- Analysts/Institutional Investor Meet/Con. Call Updates17 Jul 2026
- Certificate under SEBI (Depositories and Participants) Regulations, 20189 Jul 2026
- Copy of Newspaper Publication2 Jul 2026
- Updates1 Jul 2026
- Updates1 Jul 2026
- Shareholders meeting1 Jul 2026
- Copy of Newspaper Publication29 Jun 2026
- Trading Window29 Jun 2026
- General Updates12 Jun 2026
- Attached12 Jun 2026
The 25 most recent of 252 filings we hold for LALPATHLAB, back to January 2024. Every filing, by day.
Disclaimer
Guidance is quoted from management commentary on quarterly earnings calls; the words are the company's own and the targets are theirs, not ours. Peer comparisons use quarterly financials sourced from Screener, with every company measured at the same fiscal quarter; the peer set is companies sharing the same industry classification, and comparisons are descriptive, not a ranking or a view. Broadcast calls are reproduced as stated on air, attributed, with the analyst's SEBI registration status where given; they are not our calls and not our view. Filings are reproduced as companies filed them to the NSE and BSE; Bharatstox does not verify, endorse or comment on their contents. This page is for informational and educational purposes only and does not constitute investment advice, research, or a recommendation to buy or sell any security. Investing in securities markets is subject to market risks. Read all related documents carefully before investing.